GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sorrento Therapeutics, Inc. (SRNE) [hlAlert]

Sorrento Therapeutics, Inc. (STI) is a development-stage biopharmaceutical company focused on applying its technology platform for the discovery and development of human therapeutic antibodies for the treatment of a variety of disease conditions, including cancer, inflammation, metabolic and infectious diseases. STI had not
generated any revenue during the year ended December 31, 2009. The Company?s objective is to construct a human antibody library and, either independently or through one or more partnerships with pharmaceutical or biopharmaceutical organizations, to identify drug development candidates derived from this library. As of December 31, 2009, the Company had not developed any product candidates for commercialization. On September 21, 2009, QuikByte Software, Inc. (QuikByte) acquired STI in a reverse merger (the Merger). Pursuant to the Merger STI became a wholly owned subsidiary of QuikByte.
.
( Total: 5 Current Stock Recommendations )
Sorrento Therapeutics, Inc.   (5)
Buy 100%
Related companies
Filter by Gains:   
  
Rating:
Buy SRNE
up 58.57 %

Rating:
Buy SRNE
down 37.93 %

Rating:
Buy SRNE
up 184.00 %

Rating:
Buy SRNE
up 47.34 %

Rating:
Buy SRNE
up 51.70 %

Your Recent Stocks
SymbolLastChange
SRNE 6.68 down  -49.84 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy